Parasol Investment Management’s VanEck Biotech ETF BBH Stock Holding History

Parasol Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-75	Closed	-$10K	–	148
2015 Q4	$10K	Hold	75	–	–	0.01%	131
2015 Q3	$9K	Hold	75	–	–	0.01%	138
2015 Q2	$10K	Hold	75	–	–	0.01%	194
2015 Q1	$10K	Sell	75 -75	-50%	-$9.43K	0.01%	203
2014 Q4	$17K	Hold	150	–	–	0.01%	186
2014 Q3	$16K	Hold	150	–	–	0.01%	173
2014 Q2	$14K	Hold	150	–	–	0.01%	184
2014 Q1	$14K	Sell	150 -75	-33%	-$7.29K	0.01%	166
2013 Q4	$20K	Buy	+225	New	+$18.8K	0.01%	145

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

Parasol Investment Management's BBH Position: Q1 2016 in Review

Parasol Investment Management sold out of VanEck Biotech ETF (BBH) in Q1 2016, closing a stake of 75 shares — an estimated $10K sold.

Parasol Investment Management first reported a position in BBH in Q4 2013 and held it in 9 quarters. The position peaked at $20K in Q4 2013. 71 funds tracked by Wall St. Rank hold BBH as of Q1 2016.

Parasol Investment Management reported no remaining VanEck Biotech ETF position as of Q1 2016 after selling out during the quarter.
Parasol Investment Management sold 75 VanEck Biotech ETF shares in Q1 2016, an estimated $10K.
Parasol Investment Management first reported a position in VanEck Biotech ETF in Q4 2013 and held it in 9 quarters.
Parasol Investment Management's VanEck Biotech ETF position peaked at $20K in Q4 2013.
71 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2016.

Based on Parasol Investment Management's 13F filing for Q1 2016, filed 19 Apr 2016.